Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.3 USD | -1.39% | -18.86% | -42.15% |
May. 23 | Raymond James Adjusts Price Target on Cytokinetics to $70 From $92, Maintains Outperform Rating | MT |
May. 23 | Sector Update: Health Care Stocks Flat to Lower Premarket Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.15% | 5.54B | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Cytokinetics Insider Sold Shares Worth $2,422,918, According to a Recent SEC Filing